Gastrointestinal syrup in pharma franchise in Meghalaya

Gastrointestinal syrup in PCD pharma franchise in Jaipur

Gastrointestinal syrup in top pharma company in Shimla

Gastrointestinal syrup in pcd pharma supplier in Dispur

Gastrointestinal syrup in phama franchise company in india
Gastrointestinal Syrup of Iron syrup in phama distributor in Patna

Home/Products /sucralfate-500mg-5ml-10mg-5ml-sucrazif

About the Product

Description


Sucraziff O is a specialized gastroprotective formulation containing Sucralfate (500mg/5ml) and Oxetacaine (10mg/5ml). It is designed to provide effective relief from gastric ulcers, acid reflux, and esophagitis by forming a protective barrier over the stomach lining and reducing pain caused by excess acid.

Sucralfate acts as a mucosal protectant, forming a gel-like coating over ulcerated and inflamed areas of the stomach and intestines. This barrier shields the affected areas from stomach acid, allowing ulcers to heal more effectively. Additionally, it promotes the production of prostaglandins and bicarbonate, which further aid in mucosal protection.

Oxetacaine (also known as Oxethazaine) is a local anesthetic that provides quick pain relief by numbing the lining of the stomach and esophagus. It is especially beneficial for patients experiencing severe burning sensations, acidity, and stomach discomfort associated with ulcers or acid reflux.

Sucraziff O is recommended for individuals suffering from gastric and duodenal ulcers, acid reflux disease (GERD), esophagitis, and conditions leading to excess stomach acid production. It helps in relieving heartburn, indigestion, and discomfort caused by hyperacidity. This combination ensures long-lasting relief from gastric irritation while promoting ulcer healing.

This syrup formulation is easy to consume and should be taken on an empty stomach for optimal effectiveness. Patients are advised to follow dietary modifications and avoid irritants like spicy food, alcohol, and smoking for better results.

Common side effects may include constipation, nausea, dry mouth, dizziness, or bloating. Consult a doctor if any severe reactions occur.

Sucraziff O is indicated for the treatment of gastric ulcers, duodenal ulcers, acid reflux (GERD), and esophagitis.

Use under medical supervision. Avoid taking within 30 minutes of other medications, as it may affect absorption. Do not exceed the recommended dose.

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

1. What are the business opportunities for Sucralfate 500 mg/5 ml + Oxetacaine 10 mg/5 ml Syrup in the PCD pharma franchise market?

Sucralfate + Oxetacaine Syrup is a high-demand product in the gastroenterology, digestive care, and general medicine segment, making it an excellent addition to a PCD pharma franchise portfolio. With the rising prevalence of acidity, gastritis, heartburn, and gastric discomfort, this formulation enjoys strong prescription demand from gastroenterologists, physicians, hospitals, and retail pharmacies.

2. Why should medical distributors include Sucralfate + Oxetacaine Syrup in their product range?

Medical distributors and franchise partners can benefit from the growing demand for gastrointestinal care products. Commonly prescribed for the management of acid-related gastrointestinal disorders under medical supervision Combines a gastroprotective agent with a local anesthetic to support gastric care Frequently recommended by gastroenterologists and healthcare professionals Syrup formulation offers convenient administration and enhanced patient compliance Strong demand across hospitals, clinics, and retail pharmacy channels Widely utilized in gastroenterology and digestive health practice This strengthens a comprehensive gastroenterology and digestive care product portfolio.

3. Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Sucralfate 500 mg/5 ml + Oxetacaine 10 mg/5 ml Syrup with exclusive monopoly rights, promotional support, attractive packaging, and competitive pricing for distributors, stockists, and wholesalers throughout India.

4. What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies can benefit from: Strong prescription demand in the gastroenterology segment Consistent sales opportunities through hospitals, clinics, and pharmacies High repeat-order potential due to widespread usage Reliable product availability and supply chain support Attractive business margins and long-term growth prospects Strong acceptance among physicians and gastroenterologists These advantages contribute to sustainable sales growth and market expansion.

5. How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and pharma entrepreneurs can partner with Cafoli LifeCare Pvt Ltd to access profitable PCD pharma franchise opportunities for Sucralfate 500 mg/5 ml + Oxetacaine 10 mg/5 ml Syrup. With exclusive monopoly rights, comprehensive promotional support, quality-assured formulations, attractive profit margins, and dependable logistics services, Cafoli LifeCare Pvt Ltd helps franchise partners establish and expand a successful pharmaceutical business across India.